Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 32 results.
User Information
Export Records
  1. 1.   Xenobiotic-metabolizing gene variants, pesticide use, and the risk of prostate cancer
  2. Koutros, S.; Andreotti, G.; Berndt, S. I.; Barry, K. H.; Lubin, J. H.; Hoppin, J. A.; Kamel, F.; Sandler, D. P.; Burdette, L. A.; Yuenger, J.; Yeager, M.; Alavanja, M. C. R.; Freeman, L. E. B.
  3. Pharmacogenetics and Genomics. 2011, Oct; 21(10): 615-623.
  1. 2.   Radiosensitization of glioma cells by modulation of Met signalling with the hepatocyte growth factor neutralizing antibody, AMG102
  2. Buchanan, I. M.; Scott, T.; Tandle, A. T.; Burgan, W. E.; Burgess, T. L.; Tofilon, P. J.; Camphausen, K.
  3. Journal of Cellular and Molecular Medicine. 2011, Sep; 15(9): 1999-2006.
  1. 3.   Matriptase/epithin participates in mammary epithelial cell growth and morphogenesis through HGF activation
  2. Lee, S. L.; Huang, P. Y.; Roller, P.; Cho, E. G.; Park, D.; Dickson, R. B.
  3. Mechanisms of Development. 2010, Jan-Feb; 127(1-2): 82-95.
  1. 4.   Directed Discovery of Agents Targeting the Met Tyrosine Kinase Domain by Virtual Screening
  2. Peach, M. L.; Tan, N.; Choyke, S. J.; Giubellino, A.; Athauda, G.; Burke, T. R.; Nicklaus, M. C.; Bottaro, D. P.
  3. Journal of Medicinal Chemistry. 2009 52(4): 943-951.
  1. 5.   Identification of the genes for kidney cancer: Opportunity for disease-specific targeted therapeutics
  2. Linehan, W. M.; Pinto, P. A.; Srinivasan, R.; Merino, M.; Choyke, P.; Choyke, L.; Coleman, J.; Toro, J.; Glenn, G.; Vocke, C.; Zbar, B.; Schmidt, L. S.; Bottaro, D.; Neckers, L.
  3. Clinical Cancer Research. 2007, Jan; 13(2): 671S-679S.
  1. 6.   Oncogenic Met receptor induces ectopic structures in Xenopus embryos
  2. Ishimura, A.; Lee, H. S.; Bong, Y. S.; Saucier, C.; Mood, K.; Park, E.; Daar, I. O.
  3. Oncogene. 2006, Jul; 25(31): 4286-4299.
  1. 7.   Early onset hereditary papillary renal carcinoma: Germline missense mutations in the tyrosine kinase domain of the met proto-oncogene
  2. Schmidt, L. S.; Nickerson, M. L.; Angeloni, D.; Glenn, G. M.; Walther, M. M.; Albert, P. S.; Warren, M. B.; Choyke, P. L.; Torres-Cabala, C. A.; Merino, M. J.; Brunet, J.; Berez, V.; Borras, J.; Sesia, G.; Middelton, L.; Phillips, J. L.; Stolle, C.; Zbar, B.; Pautler, S. E.; Linehan, W. M.
  3. Journal of Urology. 2004, OCT; 172(4): 1256-1261.
  1. 8.   Genetic basis of cancer of the kidney: Disease specific approaches to therapy
  2. Linehan, W. M.; Vasselli, J.; Srinivasan, R.; Walther, M. M.; Merino, M.; Choyke, P.; Vocke, C.; Schmidt, L.; Isaacs, J. S.; Glenn, G.; Toro, J.; Zbar, B.; Bottaro, D.; Neckers, L.
  3. Clinical Cancer Research. 2004, SEP 15; 10(18, Part 2 Suppl. S): 6282S-6289S.
  1. 9.   Dysregulation of Met receptor tyrosine kinase activity in invasive tumors
  2. Danilkovitch-Miagkova, A.; Zbar, B.
  3. Journal of Clinical Investigation. 2002 109(7): 863-867.
  1. 10.   Structural basis of oncogenic activation caused by point mutations in the kinase domain of the MET proto-oncogene: Modeling studies
  2. Miller, M.; Ginalski, K.; Lesyng, B.; Nakaigawa, N.; Schmidt, L.; Zbar, B.
  3. Proteins-Structure Function and Genetics. 2001 44(1): 32-43.
  1. 11.   Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models
  2. Cao, B.; Su, Y. L.; Oskarsson, M.; Zhao, P.; Kort, E. J.; Fisher, R. J.; Wang, L. M.; Vande Woude, G. F.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2001 98(13): 7443-7448.
  1. 12.   A novel germ line juxtamembrane Met mutation in human gastric cancer
  2. Lee, J. H.; Han, S. U.; Cho, H.; Jennings, B.; Gerrard, B.; Dean, M.; Schmidt, L.; Zbar, B.; Vande Woude, G. F.
  3. Oncogene. 2000 19(43): 4947-4953.
  1. 13.   Hepatocyte growth factor-stimulated invasiveness of monocytes
  2. Beilmann, M.; Vande Woude, G. F.; Dienes, H. P.; Schirmacher, P.
  3. Blood. 2000 95(12): 3964-3969.
  1. 14.   Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells
  2. Firon, M.; Shaharabany, M.; Altstock, R. T.; Horev, J.; Abramovici, A.; Resau, J. H.; Vande Woude, G. F.,; Tsarfaty, I.
  3. Oncogene. 2000 19(20): 2386-2397.
  1. 15.   Accelerated ultraviolet radiation-induced carcinogenesis in hepatocyte growth factor/scatter factor transgenic mice
  2. Noonan, F. P.; Otsuka, T.; Bang, S.; Anver, M. R.; Merlino, G.
  3. Cancer Research. 2000 60(14): 3738-3743.
  1. 16.   Macrophage stimulating protein
  2. Leonard, E. J.; Danilkovitch, A.
  3. Advances in Cancer Research, Vol 77. 2000 77: 139-167.
  1. 17.   A src-related kinase in the brush border membranes of gastrointestinal cells is regulated by c-met
  2. Sunitha, I.; Shen, R. L.; McKillop, I. H.; Lee, J. H.; Resau, J.; Avigan, M.
  3. Experimental Cell Research. 1999 250(1): 86-98.
  1. 18.   Crystal structure of the NK1 fragment of HGF/SF suggests a novel mode for growth factor dimerization and receptor binding
  2. Chirgadze, D. Y.; Hepple, J. P.; Zhou, H. J.; Byrd, R. A.; Blundell, T. L.; Gherardi, E.
  3. Nature Structural Biology. 1999 6(1): 72-79.
  1. 19.   Somatic mutations in the kinase domain of the MET/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas
  2. Park, W. S.; Dong, S. M.; Kim, S. Y.; Na, E. Y.; Shin, M. S.; Pi, J. H.; Kim, B. J.; Bae, J. H.; Hong, Y. K.; Lee, K. S.; Lee, S. H.; Yoo, N. J.; Jang, J. J.; Pack, S.; Zhuang, Z. P.; Schmidt, L.; Zbar, B.; Lee, J. Y.
  3. Cancer Research. 1999 59(2): 307-310.
  1. 20.   Met-HGF/SF mediates growth arrest and differentiation in T47D breast cancer cells
  2. Ronen, D.; Altstock, R. T.; Firon, M.; Mittelman, L.; Sobe, T.; Resau, J. H.; Woude, G. F. V.; Tsarfaty, I.
  3. Cell Growth and Differentiation. 1999 10(2): 131-140.
  1. 21.   Alteration of Met protooncogene product expression and prognosis in breast carcinomas
  2. Tsarfaty, I.; Alvord, W. G.; Resau, J. H.; Altstock, R. T.; Lidereau, R.; Bieche, I.; Bertr, F.; Horev, J.; Klabansky, R. L.; Keydar, I.; Vande Woude, G. F.
  3. Analytical and Quantitative Cytology and Histology. 1999 21(5): 397-408.
  1. 22.   The Solution Structure of the N-Terminal Domain of Hepatocyte Growth Factor Reveals a Potential Heparin-Binding Site
  2. Zhou, H. J.; Mazzulla, M. J.; Kaufman, J. D.; Stahl, S. J.; Wingfield, P. T.; Rubin, J. S.; Bottaro, D. P.; Byrd, R. A.
  3. Structure. 1998 6(1): 109-116.
  1. 23.   Altered Expression of Transforming Growth Factor Beta-S During Urethral and Bulbourethral Gland Tumor Progression in Transgenic Mice Carrying the Androgen-Responsive C3(1) 5' Flanking Region Fused to Sv40 Large T Antigen
  2. Shibata, M. A.; Jorcyk, C. L.; Devor, D. E.; Yoshidome, K.; Rulong, S.; Resau, J.; Roche, N.; Roberts, A. B.; Ward, J. M.; Green, J. E.
  3. Carcinogenesis. 1998 19(1): 195-205.
  1. 24.   Regulation of Cardiac Development By Receptor Tyrosine Kinases
  2. Tessarollo, L.; Hempstead, B. L.
  3. Trends in Cardiovascular Medicine. 1998 8(1): 34-40.
  1. 25.   Insights Into the Structure of Hepatocyte Growth Factor Scatter Factor (Hgf/Sf) and Implications For Receptor Activation
  2. Chirgadze, D. Y.; Hepple, J.; Byrd, R. A.; Sowdhamini, R.; Blundell, T. L.; Gherardi, E.
  3. Febs Letters. 1998 430(1-2 Special Issue SI): 126-129.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel